News came out over the holiday weekend about a new variant. Followed by calls to panic.
I was listening to a meditation training the other day,
which said that one thing that happens with fear is that you cease to breathe,
or you fail to breathe deeply. If you take the time to breathe deeply, the fear
can turn to simply excitement or interest in whatever was suddenly upon you
without warning. So let’s take a moment here to breathe deeply. And then maybe
we’ll think better.
Since I’m not a doctor, just a regular person trying to make
sense of things, I’m getting my information from what I believe are reliable sources,
and I’ll try to reference those. When it’s just me trying to think things
through, I try to make that clear.
The new variant of SARS-COV-2 is called omicron. The
names have been coming from the Greek alphabet. The most recent was mu,
so the next was to be nu. And in fact the first story I heard about it
called it nu. But the namers of such things (the WHO) decided to skip nu,
because it can be confused with the word new; then any new variant after
nu would be called the new variant, confusing it with the old nu
variant.
tweet about the naming of the new variant, found here |
That brings us to O; omicron (pronounced O-mi-cron, long
O, short other vowels, accent on first syllable) is the small letter, while
omega means large O, which you would think is the capital form, but it is a
later letter in their alphabet. It’s all Greek to me, as they say. I don’t know
what names they use after they get through the Greek letters. It’s sort of like
hurricanes when they get through the entire alphabet in a season and have to
start over.
So, what do we know about this virus variant? Not a lot. But
we know that it was identified by doctors in South Africa. That doesn’t necessarily
mean it developed there rather than somewhere else; it just means that’s where
it was identified. Doctors there had been facing very few cases of SARS-COV-2
for some time; they were having something of a pause. Then they started seeing
this version. Testing showed it was SARS-COV-2 (COVID-19), but the symptoms
were not what they had been experiencing. This one showed no loss of smell or
taste. There wasn’t much of a cough. If they hadn’t been alert, they would
probably have dismissed this as just a cold and not known what they were
dealing with. And that quite likely has been happening elsewhere in the world.
It was infecting younger people, often men, around age 40.
This demographic tends to get over COVID-19 pretty easily anyway, so that may
have affected the data they have, but so far zero patients with this variant
have needed hospitalization, and zero have died. After a couple of days of
tiredness and muscle aches (about what many people experience following the
vaccine), it’s gone.
There’s some definite good news here. It seems to not be
affecting the epithelial cells in the nose and throat; that’s why no change in
taste or smell. And this also probably means no neurological damage.
From what we know so far, it is a milder version of the
illness. Again, we don’t yet know how older or more vulnerable people might
react to it. But if it becomes milder for them as well, then what we’re looking
at is a good introduction to the endemic stage of the virus—where it becomes
simply part of the background of our lives, instead of the focus.
Just to remind, because the reaction to this virus hasn’t
followed what we have always known about viruses: they mutate and create
variants. The progression is typically toward less virulence (damage to
the individual body) and more transmissibility (ability to reach more
hosts in which to replicate). That is what viruses do. That is what to expect.
And that is mainly what we’ve seen. The delta variant, while more widespread,
was milder for most people than the original.
Variants tend to leak through the vaccines. That is, the
vaccines are less effective than on the original. There’s a reason for that;
the vaccines target a particular protein, in this case the spike protein part
of the virus. When mutations happen in the vaccine-targeted protein, then the
antibodies provided by the vaccine may not recognize the virus and therefore fail
to fight it before it let it replicates enough to make a person sick.
When a person fights off the virus, they develop immunity
against the entire virus, not just the targeted protein. So the body’s immune
system recognizes the mutated virus—up until the mutations make it a totally
different virus—because there’s enough of the parts that make it that virus for
the body to recognize. If we see a large increase in reinfection (this variant
after recovery from some other variant), I think that means that then we might
be very close to having a mutation beyond SAS-COV-2. We’ve seen this with the
common cold caused by some endemic coronavirus.
We will wait and see on the vaccines, whether we have more
breakthrough cases. But since the vaccines were targeted to an earlier version,
and this particular variant alone has 32 mutations in the spike protein, we may
find that the vaccines—targeting the spike protein—are less effective on this
variant. Or not. We’ll see. But getting a booster that targets the spike
protein the way it used to be, logically, doesn’t make a lot of sense.
So, we’re back to the things that don’t make sense. Panic, for one. South Africa’s medical officials not only identified the variant, they quickly shared with the world all their findings. And, as a result, countries all over the world shut down travel from South Africa. Not a single person has been hospitalized, let alone died, from this variant, as far as we know. And yet the country that behaved well is punished for their openness.
map of travel restrictions, found here |
New York declared a state of emergency—with zero identified
cases in the state, or even in the country. And Biden imposed a travel ban that
looks suspiciously more racist than any travel ban his predecessor may have
imposed on countries not screening for terrorists. People are talking about
shutting down Christmas, returning to lockdowns and masking—for a variant that
has led to only mild cases.
The World Medical Association Chairman Frank Ulrich Montgomery says, “The new South African variant is a good example of the
mutations and us trying to prevent every possible infection and how it can’t be
done. We don’t know anything about its dangerousness yet, but it seems to be
spreading rapidly. My great concern is it could lead to a variant that is as
infectious as Delta but as dangerous as ebola.” (Glenn Beck mocks this here.)
Is this rational? Zero deaths, zero cases of hospital
admission. But someone who I would assume carries some clout in the medical
world worries it might be a very transmissible version of an almost instant
killer. Based on what?
I’d like to know whether he had this fear about the Mu
variant—you remember, the one we were supposed to be concerned about in September, even though it had been around since January and still wasn’t
overtaking Delta. Or, before that, all the other Greek
letters. Not to mention the many many variants that don’t get a label.
I learned about the new variant on Friday, when someone
linked this story:
· “New Concerning Variant: B.1.1.529” Katelyn
Jetelina on Your Local Epidemiologist blog, November 26, 2021.
This was the first news I had of the new variant. I’ve
encountered this writer before and found her not very persuasive. This article is well laid out and documented, although I would say there’s more
fear in it than the available information leads to.
So I went to Dr. Mobeen Syed, who looks at studies and data,
and then thinks through it with other doctors. It turned out that he had taken
time out of his Thanksgiving with family to look up information and share it.
That was here.
· “Omicron—How Bad Is It?” Dr. Mobeen Syed,
November 26, 2021.
He says for now there’s not a lot of reason for fear. And he
added to that a couple of days later, with a summary underneath.
· “Omicron—Different Symptoms”
Here’s his summary:
According to the Dr. Angelique Coetzee who is the Chair of
the South Africa Medical Board and a practicing GP in Pretoria, the symptoms
are extremely mild. Scratchy throat instead of cough. No anosmia and loss of
taste, however, lot of fatigue. A young child had high heart rate.
Dr. raised the alarm when four members of a family tested
positive for COVID and all suffered with exertion.
Omicron is spreading rapidly among young people. Most
patients from which the following symptoms are observed were men. Half of them
vaccinated.
No or slight cough means: shedding will be limited to
talking, laughing, etc. It will also mean that patients might not realize that
they might be shedding. However, absence of cough itself is going to reduce
shedding and spreading.
No anosmia and loss of the sense of taste is interesting. It
means that the swelling of the olfactory epithelium is not occurring (at least
in the patients she saw so far.) This also means that possible neurological
effects and possible long-haul may be less frequent.
Patients complaint of sore muscles and tiredness according to
Dr. Coetzee.
A six-year-old child had fever and very high pulse.
How is this variant behaving with older population and folks
with comorbidities is not known yet.
Omicron's (B.1.1.529) Symptoms are not like delta
(B.1.617.2), instead these are similar to beta (B.1.351 - South African
variant). No loss of sense of smell or taste. No cough or slight cough. Just
scratchy throat. However, severe muscle aches and tiredness.
Young people with body aches and pains and fatigue.
This is the account of the Dr. Angelique Coetzee. She says in
an interview to Newsroom Afrika that she has consulted with other general
practitioners. They all are observing very very mild symptoms.
No loss of smell or taste. No oxygen levels dropping at this
stage.
Dr. Mobeen Syed links to an interview Dr. Coetzee did with Newzroom Afrika and adds, “Finally, this is a single doctor’s account of her patients. We will have to wait for more data from more doctors and studies.”
Dr. Angelique Coetzee, talking about the new variant from South Africa, screenshot from here |
On Sunday night’s Crossroads, Joshua Philipp covered
the new variant among other news:
· “Live Q&A: Governments Eyeing Lockdowns Over
Omicron Variant; New Global Social Controls Emerge” Crossroads with Joshua
Philipp, November 28, 2021.
He read a comment from a viewer, Cameron Bacon, who said,
Josh, do I have amnesia, or did the Democrats and communists
go from claiming they didn’t trust the vaccine under Trump to now backing a
100-day turnaround for a variant discovered a few days ago that somehow
everyone knew about instantly?
He was referring to this story:
· “US-Based Company Developing Vaccine That Targets New COVID-19 Variant” Zachary Stieber for The Epoch Times, November 27
(updated November 29), 2021.
There is indeed an effort now underway to develop a new version
of vaccine based on this new variant. And one wonders why, if it was doable
that quickly, that they haven’t do one for the Delta variant. In fact, as the
vaccines appeared less and less effective, they pushed for more and more
boosters.
Later in the podcast Philipp was talking about natural
immunity, which ought to be news worth cheering about:
New information coming out is suggesting that people with
natural immunity are of little risk of infection. And you can have an antibody
test to see if you need it or not. You can have an antibody test. If people are
talking about actual immunity, and if governments actually cared about actual
immunity, natural immunity would be considered as part of that. Why it’s not is
beyond me.
He read from this story:
· “Naturally Immune People at Little Risk of Reinfection, Severe Disease From COVID-19: Study” Zachary Stieber for The
Epoch Times, November 27, 2021.
The story says,
Researchers in Qatar examined a cohort of over 353,000 people
using national databases that contain information about patients with
polymerase-chain-reaction-confirmed infections.
The studied population contracted COVID-19, the disease
caused by the CCP (Chinese Communist Party) virus, between Feb. 28, 2020, and
April 28, 2021.
Reinfections were counted if a person tested positive at
least 90 days after their first infection.
After excluding approximately 87,500 people with a
vaccination record, researchers found that those with immunity due to having
recovered from COVID-19 had little risk of reinfection or severe cases of the
disease.
Just 1,304 reinfections were identified. That means 0.4
percent of people with natural immunity and without a vaccination record got
COVID- 19 a second time.
The odds of severe disease were 0.1 times that of primary
infection, according to the study. Just four such cases were detected.
No cases of death were recorded among those who got infected
a second time.
It ends with this summary:
[T]he study adds
to the growing body of research that indicates that people who have recovered
from COVID-19 enjoy high levels of immunity against reinfection, and even
higher protection against severe disease and death.
There’s plenty of reason to be hopeful as we move into this
holiday season. Those who are calling for panic may have an ulterior motive—not
to protect your health, but to control your life. If you’re taking good care of
yourself, thwart them by going ahead and living your life.
Here are some additional things I’ve read or seen:
· “Biden Imposes Travel Bans He Called Trump Racist for Imposing” Robert Spencer for PJ Media, November 26, 2021.
· “It's the 'Nu' Variant. Everyone Run for Your
Lives!” Rick Moran for PJ Media, November 26, 2021.
· “Dissection of the Omicron variant” from Newzroom
Afrika interview with South African Medical Association's Dr Angelique
Coetzee, dissects the Omicron variant, which has been detected in South Africa
and is causing havoc throughout the world.
· “Omicron COVID-19 Variant Found in More Countries, Sparking Global Concern” Jack Phillips for The Epoch Times, November
29, 2021.
· “The O variant” Dr. John Campbell, November 26,
2021.
· “Omicron - Is Immune Escape Imminent? A DeepDive” Dr. Mobeen Syed, November 30, 2021.
· “Omicron good news” Dr. John Campbell, November
30, 2021.
No comments:
Post a Comment